Stifel analysts cut their stock price target for Inovio Pharmaceuticals Inc.
INO,
-6.08%
to $16 from $24 on Tuesday, after the company posted a wider-than-expected second-quarter loss and reven… [+1543 chars]
Stifel cuts COVID-19 vaccine developer Inovios price target as earnings and call leave more questions than answers – MarketWatch
